Wall Street ends sharply higher as Powell cements September rate cut hopes

By Stephen Culp NEW YORK (Reuters) -U.S. stocks rallied on Friday as dovish remarks from U.S. Federal Reserve Chair Jerome Powell solidified expectations that the central bank will cut its key policy rate in September. In highly anticipated comments before the Jackson Hole Economic Symposium, Powell said “the time has come” to lower the Fed…

Read More

Apple targets Sept. 10 debut for new iPhones, AirPods and watches, Bloomberg News reports

(Reuters) – Apple is planning its biggest product launch event of the year on Sept. 10, during which it will unveil the latest iPhones, watches and AirPods, Bloomberg News reported on Friday, citing people familiar with the situation. The company is making preparations for that date, even though the timing has not yet been announced,…

Read More

Eli Lilly Alzheimer’s drug to be blocked for use by NHS, The Telegraph reports

(Reuters) -Eli Lilly’s treatment for early Alzheimer’s is expected to be blocked for use by Britain’s National Health Service (NHS), the Telegraph reported on Friday. The drug donanemab would be rejected by the National Institute for Health and Care Excellence(NICE), which decides what drugs are available on the NHS, the newspaper reported citing insiders. The…

Read More

Microsoft to host cybersecurity summit after CrowdStrike-induced IT outage

(Reuters) -Microsoft said on Friday it would hold a summit in September on improving cybersecurity systems, after a faulty update from CrowdStrike caused a global IT outage last month. The conference marks the first big step by Microsoft to address the issues that affected nearly 8.5 million Windows devices on July 19, disrupting operations across…

Read More

Musk’s Neuralink says second trial implant went well, no thread retraction issue 

(Reuters) – Elon Musk’s brain technology startup Neuralink said its implant, designed to allow paralyzed patients to use digital devices by thinking alone, is working well in a second trial patient.  The company said the patient, identified as Alex, did not face issues of “thread retraction”, unlike Noland Arbaugh, Neuralink’s first patient who received the…

Read More

Amazon must face D.C.’s antitrust lawsuit, appeals court rules

By Jody Godoy (Reuters) – An appeals court in Washington, D.C. revived the district’s lawsuit against Amazon.com Inc on Thursday, saying it plausibly claimed the online retailer’s pricing policies illegally stifle competition. The District of Columbia Court of Appeals reversed a ruling that had dismissed the lawsuit, which accuses Amazon of harming competition through restrictions…

Read More